CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Genovate Biotechnology Co., Limited Company Snapshot
Genovate Biotechnology Co., Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genovate Biotechnology Co., Limited with three other companies in this sector in Taiwan: Johnson Chemical Pharmaceutical Works Co Ltd (2018 sales of 411.91 million Taiwanese Dollars [US$13.73 million] ), TSH Biopharm Corp Limited (515.65 million Taiwanese Dollars [US$17.19 million] of which 100% was Drug and Chemical), and Sagittarius Life Science Corp. (411.41 million Taiwanese Dollars [US$13.72 million] of which 96% was Non-toxic sector).

Sales Analysis. During the year ended December of 2018, sales at Genovate Biotechnology Co., Limited were 455.80 million Taiwanese Dollars (US$15.20 million). This is an increase of 11.6% versus 2017, when the company's sales were 408.27 million Taiwanese Dollars. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 923.2% in 2018, from 177,000.00 Taiwanese Dollars to 1.81 million Taiwanese Dollars. Genovate Biotechnology Co., Limited also saw significant increases in sales in Agency (up 87.6% to 15.19 million Taiwanese Dollars) . Not all segments of Genovate Biotechnology Co., Limited experienced an increase in sales in 2018: sales of Technical Service fell 35.1% to 12.03 million Taiwanese Dollars. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Genovate Biotechnology Co., Limited
  Stock Performance Chart for Genovate Biotechnology Co., Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2020): 24.50
(Figures in Taiwanese Dollars)
1 Week -0.4%   13 Weeks -2.2%  
4 Weeks 1.4%   52 Weeks -11.3%  
 
Genovate Biotechnology Co., Limited Key Data:
  Ticker: 4130 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 455,798,000
(Year Ending Jan 2019).
Employees: 178
  Currency: Taiwanese Dollars Market Cap: 2,577,079,050
  Fiscal Yr Ends: December Shares Outstanding: 105,186,900
  Share Type: Gu Closely Held Shares: 41,313,000
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.